Literature DB >> 28646417

Mesenchymal stem cell therapy for acute and chronic pancreatitis.

Kazumichi Kawakubo1, Shunsuke Ohnishi2, Masaki Kuwatani3, Naoya Sakamoto2.   

Abstract

Mesenchymal stem cells (MSCs) have attracted attention as a cell source for regenerative medicine. In particular, MSCs have an anti-inflammatory effect by secreting several kinds of bioactive molecules. MSC therapy is now being applied to various gastrointestinal diseases, such as graft-versus-host disease, inflammatory bowel disease, and liver cirrhosis. Therefore, MSC therapy has the potential to be a novel treatment for acute and chronic pancreatitis by suppressing inflammation. Several studies have investigated the effect of MSC therapy on acute and chronic pancreatitis, but the underlying mechanisms remain unknown. In this review, we summarize the present status of MSC therapy for acute and chronic pancreatitis.

Entities:  

Keywords:  Acute pancreatitis; Cell therapy; Chronic pancreatitis; Mesenchymal stem cells; Regenerative medicine

Mesh：

Year:  2017        PMID： 28646417     DOI： 10.1007/s00535-017-1363-9

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN： 0944-1174            Impact factor:   7.527


  38 in total

1.  Oral administration of conditioned medium obtained from mesenchymal stem cell culture prevents subsequent stricture formation after esophageal submucosal dissection in pigs.

Authors:  Takeshi Mizushima; Shunsuke Ohnishi; Hidetaka Hosono; Kenichi Yamahara; Momoko Tsuda; Yuichi Shimizu; Mototsugu Kato; Masahiro Asaka; Naoya Sakamoto
Journal:  Gastrointest Endosc       Date:  2017-01-31       Impact factor: 9.427

Review 2.  Stem Cell Therapies in Clinical Trials: Progress and Challenges.

Authors:  Alan Trounson; Courtney McDonald
Journal:  Cell Stem Cell       Date:  2015-07-02       Impact factor: 24.633

3.  Erratum to: Early diagnosis of pancreatic necrosis based on perfusion CT to predict the severity of acute pancreatitis.

Authors:  Yoshihisa Tsuji; Naoki Takahashi; Hiroyoshi Isoda; Koji Koizumi; Sho Koyasu; Miho Sekimoto; Yuichi Imanaka; Shujiro Yazumi; Masanori Asada; Yoshihiro Nishikawa; Hiroshi Yamamoto; Osamu Kikuchi; Tsukasa Yoshida; Tetsuro Inokuma; Shinji Katsushima; Naoki Esaka; Akihiro Okano; Chiharu Kawanami; Nobuyuki Kakiuchi; Masahiro Shiokawa; Yuzo Kodama; Ichiro Moriyama; Takafumi Kajitani; Yoshikazu Kinoshita; Tsutomu Chiba
Journal:  J Gastroenterol       Date:  2017-10       Impact factor: 7.527

4.  Nationwide epidemiological survey of early chronic pancreatitis in Japan.

Authors:  Atsushi Masamune; Kazuhiro Kikuta; Tatsuhide Nabeshima; Eriko Nakano; Morihisa Hirota; Atsushi Kanno; Kiyoshi Kume; Shin Hamada; Tetsuhide Ito; Motokazu Fujita; Atsushi Irisawa; Masanori Nakashima; Keiji Hanada; Takaaki Eguchi; Ryusuke Kato; Osamu Inatomi; Akio Shirane; Yoshifumi Takeyama; Ichiro Tsuji; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2017-01-27       Impact factor: 7.527

5.  Role of bone marrow-derived mesenchymal stem cells in a rat model of severe acute pancreatitis.

Authors:  Xiao-Huang Tu; Jing-Xiang Song; Xiao-Jun Xue; Xian-Wei Guo; Yun-Xia Ma; Zhi-Yao Chen; Zhong-Dong Zou; Lie Wang
Journal:  World J Gastroenterol       Date:  2012-05-14       Impact factor: 5.742

6.  Therapeutic effects of human amnion-derived mesenchymal stem cell transplantation and conditioned medium enema in rats with trinitrobenzene sulfonic acid-induced colitis.

Authors:  Shuichi Miyamoto; Shunsuke Ohnishi; Reizo Onishi; Ikuki Tsuchiya; Hidetaka Hosono; Takehiko Katsurada; Kenichi Yamahara; Hiroshi Takeda; Naoya Sakamoto
Journal:  Am J Transl Res       Date:  2017-03-15       Impact factor: 4.060

Review 7.  Stem cell therapy for inflammatory bowel disease.

Authors:  Kanna Nagaishi; Yoshiaki Arimura; Mineko Fujimiya
Journal:  J Gastroenterol       Date:  2015-01-25       Impact factor: 7.527

Review 8.  Chronic pancreatitis.

Authors:  Joan M Braganza; Stephen H Lee; Rory F McCloy; Michael J McMahon
Journal:  Lancet       Date:  2011-04-02       Impact factor: 79.321

Review 9.  Acute pancreatitis.

Authors:  Jean-Louis Frossard; Michael L Steer; Catherine M Pastor
Journal:  Lancet       Date:  2008-01-12       Impact factor: 79.321

10.  Intravenous hMSCs Ameliorate Acute Pancreatitis in Mice via Secretion of Tumor Necrosis Factor-α Stimulated Gene/Protein 6.

Authors:  Zhigang He; Jie Hua; Daohai Qian; Jian Gong; Shengping Lin; Chenglei Xu; Ge Wei; Hongbo Meng; Tingsong Yang; Bo Zhou; Zhenshun Song
Journal:  Sci Rep       Date:  2016-12-05       Impact factor: 4.379
View more
  12 in total

1.  Stem cell therapy: a potential for the perils of pancreatitis.

Authors:  Harleen Chela; Bhupinder S Romana; Markandeya Madabattula; Abdulmajeed A Albarrak; Mohamad H Yousef; Sami Samiullah; Veysel Tahan
Journal:  Turk J Gastroenterol       Date:  2020-06       Impact factor: 1.852

2.  Bone marrow-derived mesenchymal stem cells ameliorate severe acute pancreatitis by inhibiting oxidative stress in rats.

Authors:  Dongbo Zhao; Weidi Yu; Wangcheng Xie; Zhilong Ma; Zhengyu Hu; Zhenshun Song
Journal:  Mol Cell Biochem       Date:  2022-05-27       Impact factor: 3.396

Review 3.  Human Mesenchymal Stem/Stromal Cells in Immune Regulation and Therapy.

Authors:  Éva Mezey
Journal:  Stem Cells Transl Med       Date:  2022-03-17       Impact factor: 6.940

4.  Biomarkers of Chronic Pancreatitis: A systematic literature review.

Authors:  Zobeida Cruz-Monserrate; Kristyn Gumpper; Valentina Pita; Phil A Hart; Christopher Forsmark; David C Whitcomb; Dhiraj Yadav; Richard T Waldron; Stephen Pandol; Hanno Steen; Vincent Anani; Natasha Kanwar; Santhi Swaroop Vege; Savi Appana; Liang Li; Jose Serrano; Jo Ann S Rinaudo; Mark Topazian; Darwin L Conwell
Journal:  Pancreatology       Date:  2021-01-22       Impact factor: 3.996

Review 5.  Characteristics and regulation of mesenchymal stem cell plasticity by the microenvironment - specific factors involved in the regulation of MSC plasticity.

Authors:  Liping Tan; Xuan Liu; Huan Dou; Yayi Hou
Journal:  Genes Dis       Date:  2020-10-27

6.  MicroRNA-9 modified bone marrow-derived mesenchymal stem cells (BMSCs) repair severe acute pancreatitis (SAP) via inducing angiogenesis in rats.

Authors:  Daohai Qian; Guodong Song; Zhilong Ma; Guannan Wang; Lei Jin; Minghua Hu; Zhenshun Song; Xiaoming Wang
Journal:  Stem Cell Res Ther       Date:  2018-10-25       Impact factor: 6.832

Review 7.  T Lymphocytes: A Promising Immunotherapeutic Target for Pancreatitis and Pancreatic Cancer?

Authors:  Qi Zhou; Xufeng Tao; Shilin Xia; Fangyue Guo; Chen Pan; Hong Xiang; Dong Shang
Journal:  Front Oncol       Date:  2020-03-24       Impact factor: 6.244

8.  Icariin Promote Stem Cells Regeneration and Repair Acinar Cells in L-arginine / Radiation -Inducing Chronic Pancreatitis in Rats.

Authors:  Enas M Moustafa; Fatma S M Moawed; Gehan R Abdel-Hamid
Journal:  Dose Response       Date:  2020-10-30       Impact factor: 2.658

9.  Curative role of mesenchymal stromal cells in chronic pancreatitis: Modulation of MAPK and TGF-β1/SMAD factors.

Authors:  Hager S Taha; Enas M Moustafa; Fatma Sm Moawed; Marwa Ga Hegazy
Journal:  Int J Immunopathol Pharmacol       Date:  2021 Jan-Dec       Impact factor: 3.219

10.  Human umbilical cord-derived mesenchymal stem cells improve chronic pancreatitis in rats via the AKT-mTOR-S6K1 signaling pathway.

Authors:  Lijun Kong; Xiangxiang Xu; Hewei Zhang; Yi Zhou; Hongjian Huang; Bicheng Chen; Zhenxu Zhou
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.